Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT06318871
What this trial is testing

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Who this might be right for
Renal CarcinomaRenal Cell CarcinomaUrothelial Carcinoma+2 more
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT01947322
What this trial is testing

Haploidentical NK-cell Infusion in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 10
Testing effectiveness (Phase 2)Looking for participantsNCT06026657
What this trial is testing

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Negative Breast Carcinoma
Margaret Gatti-Mays 42
Early research (Phase 1)Ended earlyNCT04678453
What this trial is testing

Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)

Who this might be right for
Alzheimer DiseaseNeuro-Degenerative Disease
NKGen Biotech, Inc. 10
Early research (Phase 1)Looking for participantsNCT06751134
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, Refractory
Nanjing Children's Hospital 12
Testing effectiveness (Phase 2)UnknownNCT03634501
What this trial is testing

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

Who this might be right for
Lung CancerBreast CancerColon Cancer+2 more
Xuanwu Hospital, Beijing 200
Early research (Phase 1)UnknownNCT00799799
What this trial is testing

Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells

Who this might be right for
Myeloblastic Leukemia
University of Bologna 15
Testing effectiveness (Phase 2)Ended earlyNCT05709821
What this trial is testing

IMM60 and Pembrolizumab in Melanoma and NSCLC

Who this might be right for
Non-small Cell Lung CancerMelanoma
iOx Therapeutics 1
Early research (Phase 1)Study completedNCT02650648
What this trial is testing

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaHigh-Risk
Memorial Sloan Kettering Cancer Center 85
Not applicableUnknownNCT03665571
What this trial is testing

Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Asan Medical Center 100
Not applicableUnknownNCT02639832
What this trial is testing

A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

Who this might be right for
Triple Negative Breast CancerNatural Killer CellsBRCA Mutation
Cynvenio Biosystems 210
Not applicableUnknownNCT06458569
What this trial is testing

NK-ORB Expression of Mu Receptor on Lymphocytes in Rehabilitation

Who this might be right for
Fibromyalgia
IRCCS San Raffaele Roma 50
Not applicableEnded earlyNCT01790269
What this trial is testing

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Charite University, Berlin, Germany 21
Very early researchLooking for participantsNCT06010472
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Changhai Hospital 36
Testing effectiveness (Phase 2)Study completedNCT03056339
What this trial is testing

Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
B-Lymphoid MalignanciesAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 49
Early research (Phase 1)UnknownNCT03619954
What this trial is testing

NK Cells Infusion for Advanced Malignancies

Who this might be right for
Immunotherapy
Anhui Provincial Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06557265
What this trial is testing

NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Who this might be right for
Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc. 120
Early research (Phase 1)Study completedNCT00995137
What this trial is testing

Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoblastic Leukemia, Acute
St. Jude Children's Research Hospital 14
Early research (Phase 1)Temporarily pausedNCT05400122
What this trial is testing

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Who this might be right for
Colorectal CancerHematologic MalignancyRectum Cancer+15 more
David Wald 12
Early research (Phase 1)Study completedNCT00660166
What this trial is testing

Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

Who this might be right for
LymphomaMyelomaLeukemia
Tufts Medical Center 13
Next Page